FR1588829A - - Google Patents

Info

Publication number
FR1588829A
FR1588829A FR1588829DA FR1588829A FR 1588829 A FR1588829 A FR 1588829A FR 1588829D A FR1588829D A FR 1588829DA FR 1588829 A FR1588829 A FR 1588829A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR1588829A publication Critical patent/FR1588829A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR1588829D 1967-06-22 1968-06-24 Expired FR1588829A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1617350A DE1617350C3 (de) 1967-06-22 1967-06-22 Verfahren zur Inaktivierung von biologischem Material

Publications (1)

Publication Number Publication Date
FR1588829A true FR1588829A (fr) 1970-03-16

Family

ID=6986788

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1588829D Expired FR1588829A (fr) 1967-06-22 1968-06-24
FR167016A Expired FR8086M (fr) 1967-06-22 1968-09-20

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR167016A Expired FR8086M (fr) 1967-06-22 1968-09-20

Country Status (9)

Country Link
JP (1) JPS494932B1 (fr)
AT (1) AT279041B (fr)
BE (1) BE717053A (fr)
BR (1) BR6800054D0 (fr)
CH (1) CH562612A5 (fr)
DE (1) DE1617350C3 (fr)
FR (2) FR1588829A (fr)
IL (1) IL30206A (fr)
LU (1) LU56297A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2406999A1 (fr) * 1977-10-27 1979-05-25 Behringwerke Ag Stabilisant pour polysaccharides de meningocoques
EP0130619A2 (fr) * 1983-07-05 1985-01-09 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Vaccin contre l'hépatite B et méthode de préparation
EP0171506A1 (fr) * 1982-05-13 1986-02-19 Cedars-Sinai Medical Center Procédé de traitement du plasma ou de fractions du plasma par la chaleur et compositions ainsi obtenues
WO2002028362A2 (fr) * 2000-10-06 2002-04-11 Aventis Pasteur Composition vaccinale et procede de stabilisation

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6122331U (ja) * 1984-07-16 1986-02-08 マルコン電子株式会社 回転機用コンデンサ
JPS6286707A (ja) * 1985-10-02 1987-04-21 アテシ 高電圧高エネルギ−密度コンデンサ

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2406999A1 (fr) * 1977-10-27 1979-05-25 Behringwerke Ag Stabilisant pour polysaccharides de meningocoques
EP0171506A1 (fr) * 1982-05-13 1986-02-19 Cedars-Sinai Medical Center Procédé de traitement du plasma ou de fractions du plasma par la chaleur et compositions ainsi obtenues
EP0130619A2 (fr) * 1983-07-05 1985-01-09 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Vaccin contre l'hépatite B et méthode de préparation
EP0130619A3 (en) * 1983-07-05 1985-04-10 Chemo Sero Therapeut Res Inst Hepatitis b vaccine and method for its preparation
WO2002028362A2 (fr) * 2000-10-06 2002-04-11 Aventis Pasteur Composition vaccinale et procede de stabilisation
FR2814957A1 (fr) * 2000-10-06 2002-04-12 Aventis Pasteur Composition vaccinale et procede de stabilisation
WO2002028362A3 (fr) * 2000-10-06 2003-09-12 Aventis Pasteur Composition vaccinale et procede de stabilisation

Also Published As

Publication number Publication date
DE1617350B2 (de) 1979-01-11
AT279041B (de) 1970-02-25
DE1617350A1 (de) 1971-03-25
LU56297A1 (fr) 1970-01-15
IL30206A0 (en) 1968-08-22
CH562612A5 (en) 1975-06-13
FR8086M (fr) 1970-07-20
DE1617350C3 (de) 1979-09-06
BE717053A (fr) 1968-12-24
JPS494932B1 (fr) 1974-02-04
IL30206A (en) 1972-05-30
BR6800054D0 (pt) 1973-02-13

Similar Documents

Publication Publication Date Title
AU425114B2 (fr)
AU416737B2 (fr)
AU342066A (fr)
AU2277767A (fr)
AU610966A (fr)
AU2116667A (fr)
AU2256867A (fr)
AU2977667A (fr)
AU1273466A (fr)
AU3189468A (fr)
RO56232A (fr)
AU2528767A (fr)
AU97666A (fr)
BE609934A (fr)
AU25066A (fr)
AU2406369A (fr)
AU34866A (fr)
AU408412B2 (fr)
AU23366A (fr)
AU1868267A (fr)
BE692654A (fr)
AU1763766A (fr)
AU1677166A (fr)
BE692778A (fr)
BE162295A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse
CL Concession to grant licences